Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 371, Issue 19, Pages 1781-1792
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2014-11-06
DOI
10.1056/nejmoa1316133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FRI0150 Maintenance of remission in rheumatoid arthritis patients with low-moderate disease activity following withdrawal of certolizumab PEGOL treatment: Week 52 results from the certain study
- (2014) J.S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission
- (2014) Masao Nawata et al. Modern Rheumatology
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
- (2013) Josef S Smolen et al. LANCET
- Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
- (2013) Josef S Smolen et al. LANCET
- Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and
- (2012) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study
- (2012) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
- (2012) Yoshiya Tanaka CURRENT OPINION IN RHEUMATOLOGY
- Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
- (2011) S. Bosello et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosis
- (2011) Kana Hoshino et al. ARTHRITIS AND RHEUMATISM
- High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: Results of an international multicenter collaborative study
- (2011) Naoko Tanaka et al. ARTHRITIS AND RHEUMATISM
- Treating rheumatoid arthritis to target: recommendations of an international task force
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study
- (2010) N. B. Klarenbeek et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
- (2010) B. Saleem et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
- (2010) Y. Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: A two-year, double-blind, randomized study
- (2010) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis
- (2010) V. Bejarano et al. RHEUMATOLOGY
- Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
- (2009) J Kekow et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment
- (2009) D. Aletaha et al. ARTHRITIS AND RHEUMATISM
- The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial
- (2009) Vappu Rantalaiho et al. ARTHRITIS AND RHEUMATISM
- Effect of discontinuing TNFα antagonist therapy in patients with remission of rheumatoid arthritis
- (2009) Olivier Brocq et al. JOINT BONE SPINE
- Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis
- (2009) P. EMERY et al. JOURNAL OF RHEUMATOLOGY
- Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis
- (2008) S M van der Kooij et al. ANNALS OF THE RHEUMATIC DISEASES
- Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
- (2008) J S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started